Skip to main content

Day: April 7, 2021

AGF DÉCLARE LE TOTAL DE SON ACTIF GÉRÉ POUR MARS 2021

TORONTO, 07 avr. 2021 (GLOBE NEWSWIRE) — La Société de Gestion AGF Limitée a déclaré un actif géré global donnant droit à des honoraires de 40,5 milliards de dollars pour le mois terminé le 31 mars 2021.Actif géré(en milliards $) 31 mars2021 28 février2021 % dechangementd’un moissur l’autre 31 mars2020 % dechangementd’une annéesur l’autreTotal des FCP(y compris les fonds en gestion commune de détail) 21,8 $ 21,4 $   16,7 $  Comptes institutionnels, de sous-conseillers,de particuliers bien nantis et de fonds négociés en bourse 16,0 $ 15,7 $   14,7 $  Sous-total de l’actif géré(avant l’actif géré de la plateforme d’alternatifs privés) 37,8 $ 37,1 $   31,4 $  Actif géré de la plateforme d’alternatifs privés 2,7 $ 2,7 $   2,9 $  Total de l’actif géré 40,5 $ 39,8 $ 1,8 % 34,3 $ 18,1 %           Actif géré quotidien...

Continue reading

Kering – Information regarding the arrangements for taking part in the Combined General Meeting of April 22, 2021 and conditions for obtaining or consulting the documents prepared for the Meeting

                       PRESS RELEASE04.07.2021INFORMATION REGARDING THE ARRANGEMENTS FOR TAKING PART IN THE COMBINED GENERAL MEETING OF APRIL 22, 2021AND CONDITIONS FOR OBTAINING OR CONSULTING THE DOCUMENTS PREPARED FOR THE MEETING Kering shareholders are invited to take part in the Company’s Combined General Meeting to be held at 3 p.m. (Paris Time) on Thursday, April 22, 2021.In light of the ongoing health crisis situation and the administrative measures taken in the context of the COVID-19 pandemic, the General Meeting will take place behind closed doors, without the physical presence of shareholders1. The General Meeting will be broadcast live and a replay will also be available on the Company’s website2: https://www.kering.com/en/ (Finance/Shareholders information/Annual General Meeting section). As the General Meeting is...

Continue reading

Kering – Informations relatives aux modalités de tenue de l’Assemblée générale mixte du 22 avril 2021 et modalités de mise à disposition ou de consultation des documents préparatoires

COMMUNIQUÉ DE PRESSE07.04.2021INFORMATIONS RELATIVES AUX MODALITÉS DE TENUE DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 22 AVRIL 2021ET MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de Kering sont invités à participer à l’Assemblée générale mixte qui se déroulera le jeudi 22 avril 2021 à 15 heures (heure de Paris).Compte tenu du prolongement de l’état d’urgence sanitaire et au regard des mesures administratives prises dans le cadre de la pandémie de COVID-19, l’Assemblée générale se tiendra à huis clos, hors la présence physique des actionnaires1. L’Assemblée générale sera diffusée en direct et également disponible en différé sur le site Internet de la Société2 : https://www.kering.com/fr (rubrique Finance / Informations Actionnaires / Assemblée générale). L’Assemblée générale se tenant hors...

Continue reading

ContextVision – Invitation to Annual General Meeting 2021

STOCKHOLM – April 7, 2021 – ContextVision hereby invites shareholders to the Annual General Meeting on May 5, 2021. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM. For inquiries, please contact CFO Ann-Charlotte LinderothE-mail: ann-charlotte.linderoth@contextvision.se ### About ContextVisionContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge...

Continue reading

ContextVision – Kallelse till årsstämma 2021

STOCKHOLM – 7 april, 2021 – ContextVision kallar härmed aktieägare till årsstämma den 5:e maj 2021. Bifogat finns kallelse inklusive dagordning och instruktioner för registrering och röstning. Vänligen kontakta: finance@contextvision.se för frågor gällande årsstämman. För övriga frågor, vänligen kontakta CFO Ann-Charlotte LinderothE-post: ann-charlotte.linderoth@contextvision.se ### Om ContextVisionContextVision är ett medicintekniskt mjukvaruföretag specialiserat på bildanalys och artificiell intelligens. Som den globala marknadsledaren inom bildbehandling är vi en etablerad partner till ledande tillverkare av ultraljud, röntgen och magnetkamerautrustning runt om i världen. Vår expertis är att utveckla kraftfulla mjukvaruprodukter baserade på egenutvecklad teknologi och artificiell intelligens för bildbaseradetillämpningar. Våra högteknologiska...

Continue reading

Disposable Medical Gloves Market Size 2021 | To hit USD 14.03 billion by the end of 2027 with 10.6% CAGR

Pune, India, April 07, 2021 (GLOBE NEWSWIRE) — The global disposable medical gloves market is projected to gain impetus from the increasing awareness about health and safety, especially after the COVID-19 pandemic. Medical gloves or disposable gloves are used by medical practitioners during surgical or examining procedures. “The market will hit USD 14.03 billion by the end of 2027 from USD 5.95 billion in the year 2019. The forecast period is set between 2020 to 2027, and the market is expected to rise at a CAGR of 10.6% “ North America Held Largest Share Owing to Stringent Health Regulations Imposed by Government on Personal Health and Safety Geographically, North America earned USD 2.26 billion and emerged as the region with the highest disposable medical gloves market share in 2019, followed by Europe. This is attributable to...

Continue reading

Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases

Data from Initial Patient Cohorts of Phase 2 AFFINITY Study Expected to be Reported in 2022 SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the first patient has been dosed in the AFFINITY Study, a phase 2 clinical trial evaluating the efficacy and safety of atrasentan, a potent and selective inhibitor of the endothelin A receptor, in patients with proteinuric glomerular disease who are at risk of progressive loss of renal function. “Initiation of the phase 2 AFFINITY Study is an important step in evaluating atrasentan across multiple proteinuric glomerular diseases for which there are currently limited treatment options,” said Alan Glicklich,...

Continue reading

Agillic implements changes to the board of directors and issues 105,500 new warrants. Three current and former leading employees exercise warrants

Announcement no. 11 2021 Copenhagen – 7 April 2021 – Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC), the Copenhagen-based marketing automation Software-as-a-Service (SaaS) company announces, that it has elected Susanne Lund as a new member of the board of directors and has extended its shared-based incentive program with 105,500 new warrants.  On the ordinary annual general meeting 30 March 2021, Susanne Lund was elected as new member of Agillic’s board of directors. At the same time, Peter Elbek stepped down from the board of directors. Says Johnny Henriksen, chair of Agillic: “I am delighted to welcome Susanne Lund to the board of directors and to announce that Agillic has extended the Company’s current warrant program as part of the Company’s reboot 2.1 strategy. A key element in the strategy...

Continue reading

AI Market to Reach USD 266.92 Bn by 2027 at 33.2% CAGR; Tech Giants Such as Google and Amazon to Focus on Developing AI-powered Services for End Users: Fortune Business Insights™

Pune, India, April 07, 2021 (GLOBE NEWSWIRE) — The overall AI market is expected to grow from USD 27.23 Billion in 2019 to USD 266.92 Billion by 2027 at a CAGR of 33.1% during the forecast period. Emergence of the COVID-19 pandemic is generating several growth opportunities for the market, observes Fortune Business Insights™ in its report, titled “Artificial Intelligence Market Size, Share & COVID-19 Impact Analysis, By Component (Hardware, Software, and Services), By Technology (Computer Vision, Machine Learning, Natural Language Processing, and Others), By Deployment (Cloud, On-premises), By Industry (Healthcare, Retail, IT & Telecom, BFSI, Automotive, Advertising & Media, Manufacturing, and Others) and Regional Forecast, 2020-2027”. Smart technologies are being extensively utilized around the globe to battle the...

Continue reading

Commercial Vehicle Market Size 2021 | To Reach USD 621.1 Billion by 2027; Rapid Industrialization and Increasing Efforts towards Infrastructure Development Will Aid Growth, says Fortune Business Insights™

Pune, India, April 07, 2021 (GLOBE NEWSWIRE) — According to the report, Commercial Vehicle market size is projected to reach USD 621.1 billion value by 2027. The increasing IT sector and rapid industrialization across the globe will emerge in favor of market growth. The market was worth USD 748.6 billion in 2019 and will exhibit a CAGR of -2.3% during the forecast period 2020-2027.               The COVID-19 pandemic has dealt severe blows on the automotive industry. When the pandemic erupted, governments announced lockdowns and social distancing measures to contain the spread of the virus. As a result, several carmakers, such as Fiat and PSA Group, were forced to close down their plants to comply with the new regulations. These adverse developments triggered by the pandemic will have repercussions for markets associated with the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.